NCT02749487View on ClinicalTrials.gov

Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

September 30, 2016

Conditions
Critical Care
Interventions
OTHER

Neutrophil Lymphocyte Ratio

Neutrophil:lymphocyte ratio (NLR) is an emerging biomarker that is used to predict mortality and morbidity. The association of this biomarker with systemic illness and its usefulness in risk assessment of critically ill patients has not been fully elucidated.

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02749487 - Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients | Biotech Hunter | Biotech Hunter